Feedback / Questions
NOD2 - Nodus Oncology
https://www.globenewswire.com/news-release/2022/09/08/2512091/0/en/Nodus-Oncology-announces-acquisition-of-Basilea-Pharmaceutica-s-PARG-inhibitor-programme.html
 
Sep 8, 2022
 
SHARE THIS
  • Print
  • Email
  • More sharing
    Reddit
    StumbleUpon
    Delicious